ATE153383T1 - Rekombinante dna-methode und vektoren, die dafür benutzt werden - Google Patents

Rekombinante dna-methode und vektoren, die dafür benutzt werden

Info

Publication number
ATE153383T1
ATE153383T1 AT90916069T AT90916069T ATE153383T1 AT E153383 T1 ATE153383 T1 AT E153383T1 AT 90916069 T AT90916069 T AT 90916069T AT 90916069 T AT90916069 T AT 90916069T AT E153383 T1 ATE153383 T1 AT E153383T1
Authority
AT
Austria
Prior art keywords
gene
glutamine
recombinant dna
vectors used
dna method
Prior art date
Application number
AT90916069T
Other languages
English (en)
Inventor
Christopher Robert Bebbington
Geoffrey Thomas Yarranton
Original Assignee
Celltech Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celltech Therapeutics Ltd filed Critical Celltech Therapeutics Ltd
Application granted granted Critical
Publication of ATE153383T1 publication Critical patent/ATE153383T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heat-Exchange Devices With Radiators And Conduit Assemblies (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT90916069T 1989-10-25 1990-10-25 Rekombinante dna-methode und vektoren, die dafür benutzt werden ATE153383T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898924021A GB8924021D0 (en) 1989-10-25 1989-10-25 Recombinant dna method and vectors for the use therein

Publications (1)

Publication Number Publication Date
ATE153383T1 true ATE153383T1 (de) 1997-06-15

Family

ID=10665141

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90916069T ATE153383T1 (de) 1989-10-25 1990-10-25 Rekombinante dna-methode und vektoren, die dafür benutzt werden

Country Status (11)

Country Link
EP (1) EP0491875B1 (de)
JP (1) JP3073009B2 (de)
AT (1) ATE153383T1 (de)
AU (1) AU6629990A (de)
CA (1) CA2071543C (de)
DE (1) DE69030768T2 (de)
DK (1) DK0491875T3 (de)
ES (1) ES2104616T3 (de)
GB (1) GB8924021D0 (de)
GR (1) GR3023510T3 (de)
WO (1) WO1991006657A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7597886B2 (en) 1994-11-07 2009-10-06 Human Genome Sciences, Inc. Tumor necrosis factor-gamma
CA2257357C (en) 1996-06-07 2010-04-13 Neorx Corporation Humanized antibodies with modified glycosylation
EP2213743A1 (de) 2000-04-12 2010-08-04 Human Genome Sciences, Inc. Albuminfusionsproteine
US20030031675A1 (en) 2000-06-06 2003-02-13 Mikesell Glen E. B7-related nucleic acids and polypeptides useful for immunomodulation
EP2431054A3 (de) 2000-06-15 2013-03-06 Human Genome Sciences, Inc. Menschlicher Tumornekrosefaktor Delta und Ypsilon
JP2004536579A (ja) 2001-04-13 2004-12-09 ヒューマン ジノーム サイエンシーズ, インコーポレイテッド 血管内皮増殖因子2
US7064189B2 (en) 2001-05-25 2006-06-20 Human Genome Sciences, Inc. Antibodies that immunospecifically bind to trail receptors
US20080194481A1 (en) 2001-12-21 2008-08-14 Human Genome Sciences, Inc. Albumin Fusion Proteins
AU2002364586A1 (en) 2001-12-21 2003-07-30 Delta Biotechnology Limited Albumin fusion proteins
WO2003066824A2 (en) 2002-02-07 2003-08-14 Aventis Behring Gmbh Albumin-fused kunitz domain peptides
HUE027902T2 (en) 2004-02-09 2016-11-28 Human Genome Sciences Inc Corp Service Company Albumin fusion proteins
US7973139B2 (en) 2004-03-26 2011-07-05 Human Genome Sciences, Inc. Antibodies against nogo receptor
US9505823B2 (en) 2006-08-07 2016-11-29 TEV A Biopharmaceuticals USA, Inc. Albumin-insulin fusion proteins
US9540426B2 (en) 2009-10-06 2017-01-10 Bristol-Myers Squibb Company Mammalian cell culture processes for protein production
EP2325322A1 (de) 2009-11-23 2011-05-25 4-Antibody AG Retrovirusvektorpartikel und Verfahren zu deren Erzeugung und Verwendung
WO2012095514A1 (en) 2011-01-14 2012-07-19 Vivalis Recombinant protein production system
AU2012222833B2 (en) 2011-03-03 2017-03-16 Zymeworks Inc. Multivalent heteromultimer scaffold design and constructs
US20140356863A1 (en) 2011-11-21 2014-12-04 Bristol-Myers Squibb Company Methods for determining the susceptibility of a virus to an attachment inhibitor
US9657310B2 (en) 2012-04-27 2017-05-23 Jcr Pharmaceuticals Co., Ltd. Expression vector
EP2674495A1 (de) * 2012-06-14 2013-12-18 Sanofi CHO-Expressionssystem
WO2014012082A2 (en) 2012-07-13 2014-01-16 Zymeworks Inc. Multivalent heteromultimer scaffold design an constructs
JP2015531244A (ja) 2012-10-15 2015-11-02 ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company タンパク質を製造するための哺乳動物細胞培養方法
WO2014182970A1 (en) 2013-05-08 2014-11-13 Zymeworks Inc. Bispecific her2 and her3 antigen binding constructs
CA2874083C (en) 2014-12-05 2024-01-02 Universite Laval Tdp-43-binding polypeptides useful for the treatment of neurodegenerative diseases
WO2016130734A1 (en) 2015-02-11 2016-08-18 Bristol-Myers Squibb Company Use of phenolic antioxidants in cell culture for the production of proteins
WO2017083224A1 (en) 2015-11-09 2017-05-18 Bristol-Myers Squibb Company Methods to manipulate quality attributes of polypeptides produced in cho cells

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8601597D0 (en) * 1986-01-23 1986-02-26 Wilson R H Nucleotide sequences
EP0319206A3 (de) * 1987-11-30 1990-04-18 Berlex Laboratories, Inc. Gen-Vermehrung
GB8809129D0 (en) * 1988-04-18 1988-05-18 Celltech Ltd Recombinant dna methods vectors and host cells

Also Published As

Publication number Publication date
GB8924021D0 (en) 1989-12-13
CA2071543C (en) 2005-02-22
GR3023510T3 (en) 1997-08-29
ES2104616T3 (es) 1997-10-16
WO1991006657A1 (en) 1991-05-16
AU6629990A (en) 1991-05-31
EP0491875B1 (de) 1997-05-21
CA2071543A1 (en) 1991-04-26
EP0491875A1 (de) 1992-07-01
JPH05504050A (ja) 1993-07-01
JP3073009B2 (ja) 2000-08-07
DE69030768D1 (de) 1997-06-26
DK0491875T3 (da) 1997-06-16
DE69030768T2 (de) 1997-10-16

Similar Documents

Publication Publication Date Title
ATE153383T1 (de) Rekombinante dna-methode und vektoren, die dafür benutzt werden
Lucibello et al. Periodic cdc25C transcription is mediated by a novel cell cycle‐regulated repressor element (CDE).
DK639689D0 (da) Indfoering af dna i celler
NO964445L (no) DNA-sekvens, vektor, vertscelle og fremgangsmåte for transfeksjon av hematopoeseceller med eksogen DNA
DE69524105D1 (de) Verwendung von rna-polymerase zur verbesserung von nukeinsaeure-amplifikationsverfahren
JP2008086326A (ja) ゲノム性要素を使用する遺伝子の操作および発現
ATE198355T1 (de) Alpha-amidierende enzymzusammensetzungen und verfahren zu deren herstellung und verwendung
EP0484374A4 (en) Rapid, versatile and simple system for expressing genes in eukaryotic cells
ATE120237T1 (de) Rekombinante dns-verfahren, verktoren und wirtszellen.
GB8810400D0 (en) Analysing polynucleotide sequences
DE3568939D1 (en) Bone implant
DK101385A (da) Molekylaer kloning og ekspression i industrielle mikroorganismearter
Hirsch et al. Comparison of abundant cytosol proteins in rat liver, Novikoff hepatoma, and Morris hepatoma by two-dimensional gel electrophoresis
DE69033961D1 (de) Zellinien, die einen biologisch aktiven faktor-ix exprimieren
ES8400265A1 (es) Aparato para la extrusion continua accionada por friccion.
IL65732A (en) Diaphragm,in particular for electrolysis cell,process for the preparation thereof,and an electrolytic cell comprising the same
Lau et al. Proteins of transcriptionally active and inactive chromatin from Friend erythroleukemia cells
DE3069489D1 (en) Expandable electrode suitable for use in an electrolytic cell of the diaphragm or membrane type, and said electrolytic cell
CA2231745A1 (en) In-vitro transcription processes for screening natural products and other chemical substances
DE3684017D1 (de) Vielfach amplifizierbare vektoren fuer hohe expression exogener dns.
SE8404637L (sv) Plasmidvektorer med hogt kopeieringstal, framstellning och anvendning derav
MX9600860A (es) Metodo para detectar polimorfismo de gen p4501a2 de citocromo humano.
IT8123212A0 (it) Procedimento per la polimerizzazione e copolimerizzazione in alta resa dicomposti olefinicamente insaturi e mezzi adatti allo socpo.
ELLIS An experimental study of biaxial yield in modified 9 Cr-1 Mo steel at room temperature(Final Report)
Jones Sensitivity of transcription by purified Streptomyces antibioticus RNA polymerase to actinomycin

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
EELA Cancelled due to lapse of time